Profile data is unavailable for this security.
About the company
Siemens Healthineers AG is a Germany-based company. The Company is a global provider of healthcare products, solutions and services. It also provides clinical consulting services and training and service offerings. The Company’s segments include Imaging, Diagnostics, Varian, and Advanced Therapies. The Imaging segment offers a software solutions to support the reading and structured reporting of diagnostic images from different modalities. The Diagnostics segment offers to healthcare providers in the fields of general laboratory, specialty laboratory, and point-of-care diagnostics. The Varian segment offers a portfolio of cancer care technologies and services and support oncology departments in hospitals and clinics. The Advanced Therapies segment consists of integrated products, services and solutions used in the treatment of diseases across multiple clinical fields.
- Revenue in EUR (TTM)23.30bn
- Net income in EUR2.12bn
- Incorporated2017
- Employees72.80k
- LocationSiemens Healthineers AGSiemensstr. 3FORCHHEIM 91301GermanyDEU
- Phone+49 6 966826602
- Websitehttps://www.siemens-healthineers.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| BioMerieux SA | 4.12bn | 377.90m | 10.95bn | 14.75k | 29.11 | 2.78 | 12.82 | 2.66 | 3.18 | 3.18 | 34.66 | 33.32 | 0.7715 | 1.81 | 5.96 | 279,368.30 | 6.94 | 9.22 | 8.56 | 11.94 | 56.27 | 56.58 | 8.99 | 12.35 | 1.30 | 43.19 | 0.1139 | 20.24 | 8.31 | 8.27 | 20.86 | 9.64 | 4.88 | 36.49 |
| Sonova Holding AG | 4.22bn | 570.09m | 12.84bn | 18.04k | 22.56 | 4.83 | 15.17 | 3.05 | 8.71 | 8.71 | 64.41 | 40.72 | 0.7019 | 2.42 | 7.21 | 213,874.40 | 9.62 | 10.74 | 12.57 | 13.66 | 71.66 | 72.16 | 13.71 | 17.50 | 0.9087 | 16.87 | 0.377 | 42.61 | 6.58 | 5.79 | -10.07 | 5.22 | 1.33 | -- |
| Smith & Nephew plc | 5.01bn | 414.25m | 12.86bn | 17.00k | 32.12 | 2.84 | 13.42 | 2.56 | 0.4116 | 0.4116 | 4.98 | 4.66 | 0.5599 | 0.7184 | 4.26 | 252,533.50 | 4.62 | 3.62 | 5.48 | 4.41 | 70.04 | 70.47 | 8.26 | 7.10 | 1.40 | 7.24 | 0.3842 | 87.54 | 4.70 | 2.49 | 56.65 | -7.24 | -1.36 | -2.01 |
| Coloplast A/S | 3.73bn | 533.92m | 13.64bn | 16.98k | 27.37 | 7.91 | 18.66 | 3.65 | 17.71 | 17.71 | 123.79 | 61.25 | 0.5743 | 2.38 | 6.12 | 1,625,729.00 | 8.21 | 12.75 | 10.44 | 17.10 | 67.87 | 67.86 | 14.30 | 18.95 | 0.8122 | 9.75 | 0.6451 | 100.37 | 3.12 | 8.49 | -28.03 | -2.83 | 8.92 | 5.02 |
| Sartorius AG | 3.54bn | 155.00m | 15.27bn | 14.04k | 81.16 | 4.65 | 23.47 | 4.32 | 2.24 | 2.24 | 51.24 | 39.20 | 0.357 | 2.41 | 12.72 | 251,965.50 | 2.33 | 5.04 | 3.27 | 7.04 | 46.26 | 48.75 | 6.52 | 11.14 | 0.4951 | 3.07 | 0.5255 | 23.33 | 4.66 | 8.66 | 84.40 | -5.91 | 12.96 | 0.8428 |
| Sartorius Stedim Biotech SA | 2.97bn | 265.80m | 16.61bn | 10.10k | 62.73 | 4.06 | 28.44 | 5.60 | 2.72 | 2.72 | 30.39 | 42.04 | 0.3655 | 2.36 | 12.94 | 293,870.10 | 3.28 | 6.74 | 3.85 | 8.13 | 45.33 | 48.14 | 8.97 | 13.76 | 0.5313 | 3.91 | 0.3865 | 21.88 | 6.74 | 9.21 | 51.68 | -4.59 | 19.82 | 0.2924 |
| Straumann Holding AG | 2.83bn | 468.84m | 16.83bn | 11.95k | 35.93 | 7.47 | 26.34 | 5.96 | 2.68 | 2.47 | 16.15 | 12.90 | 0.7378 | 1.72 | 4.23 | 218,270.60 | 12.29 | 12.06 | 16.00 | 15.54 | 71.24 | 74.11 | 16.65 | 17.39 | 1.13 | 10.42 | 0.1743 | 32.23 | 9.98 | 9.42 | 2.11 | 8.35 | 2.28 | 10.56 |
| Koninklijke Philips NV | 17.83bn | 900.00m | 25.24bn | 64.82k | 27.97 | 2.28 | 12.47 | 1.42 | 0.9371 | 0.9317 | 18.65 | 11.52 | 0.6378 | 3.22 | 4.95 | 275,143.90 | 3.22 | -0.9494 | 4.48 | -1.30 | 45.18 | 44.19 | 5.05 | -1.57 | 0.9405 | 8.09 | 0.4239 | -- | -1.04 | 0.5947 | 206.52 | -1.93 | -5.68 | -- |
| Alcon AG | 8.59bn | 882.83m | 33.90bn | 25.60k | 38.21 | 1.80 | 17.06 | 3.95 | 1.62 | 1.62 | 15.78 | 34.37 | 0.3292 | 1.94 | 5.58 | 306,238.30 | 3.38 | 1.51 | 3.71 | 1.66 | 54.26 | 54.08 | 10.28 | 5.03 | 1.30 | 17.58 | 0.1917 | 25.74 | 4.82 | 5.71 | 4.52 | -- | -0.1782 | -- |
| Siemens Healthineers AG | 23.30bn | 2.12bn | 46.06bn | 72.80k | 21.67 | 2.50 | 13.03 | 1.98 | 1.88 | 1.88 | 20.72 | 16.34 | 0.5032 | 3.18 | 3.73 | 319,109.60 | 4.63 | 4.33 | 6.37 | 5.86 | 38.44 | 37.61 | 9.20 | 8.82 | 0.7162 | 10.64 | 0.4426 | 53.94 | 4.53 | 10.08 | 10.40 | 8.73 | 7.99 | 4.56 |
| EssilorLuxottica SA | 28.49bn | 2.32bn | 112.63bn | 200.00k | 48.74 | 2.89 | 20.31 | 3.95 | 4.99 | 4.99 | 61.31 | 83.99 | 0.4446 | 3.43 | 8.26 | 142,455.00 | 3.81 | 3.71 | 4.69 | 4.46 | 59.69 | 61.57 | 8.57 | 9.01 | 0.6966 | 17.40 | 0.2672 | -- | 7.48 | 14.58 | -1.87 | 93.65 | 18.60 | -- |
Data as of Feb 18 2026. Currency figures normalised to Siemens Healthineers AG's reporting currency: Euro EUR
6.66%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Norges Bank Investment Managementas of 30 Jun 2025 | 20.06m | 1.78% |
| The Vanguard Group, Inc.as of 04 Feb 2026 | 11.08m | 0.98% |
| T. Rowe Price International Ltd.as of 05 Feb 2026 | 8.48m | 0.75% |
| FIL Investments Internationalas of 31 Dec 2025 | 8.19m | 0.73% |
| BlackRock Fund Advisorsas of 06 Feb 2026 | 6.55m | 0.58% |
| Amundi Ireland Ltd.as of 02 Feb 2026 | 4.75m | 0.42% |
| Harris Associates LPas of 06 Feb 2026 | 4.45m | 0.39% |
| BlackRock Asset Management Deutschland AGas of 06 Feb 2026 | 4.20m | 0.37% |
| Geode Capital Management LLCas of 12 Feb 2026 | 3.79m | 0.34% |
| Amundi Asset Management SASU (Investment Management)as of 10 Feb 2026 | 3.56m | 0.32% |
More ▼
Data from 30 Sep 2025 - 31 Dec 2025Source: FactSet Research Systems Inc.
